Literature DB >> 29532502

Administering atropine and ketamine before less invasive surfactant administration resulted in low pain scores in a prospective study of premature neonates.

L Bourgoin1, L Caeymaex1, F Decobert1,2, C Jung3, C Danan1,2,3, X Durrmeyer1,2.   

Abstract

AIM: Less invasive surfactant administration (LISA) can avoid tracheal intubation for neonatal respiratory distress syndrome, but can be painful because it requires laryngoscopy. The aim of this study was to assess the efficacy and tolerance of intravenous atropine plus ketamine administration before LISA.
METHODS: We conducted a prospective observational study of all premature infants hospitalised in our French neonatal intensive care unit treated with LISA between March 2015 and March 2016. Ketamine was titrated by 0.5 mg/kg increments. The technical conditions, pain scores, emergent intubations and vital signs were collected and analysed.
RESULTS: Values are reported as medians (interquartile ranges). We included 29 patients with a gestational age of 29.6 (28.6-30.9) weeks and birth weight of 1290 (945-1600) grams. Technical conditions were satisfying for 24 infants (83%). The Faceless Acute Neonatal Pain Scale score was 2 (2-4); seven infants (24%) required tracheal intubation before LISA could be performed; 17 (59%) had a pulse oxymetry value under 80% that lasted more than 60 seconds. Heart rate and mean arterial blood pressure transiently increased.
CONCLUSION: Atropine plus ketamine before LISA resulted in low pain scores and stable haemodynamic parameters, but prolonged desaturations or apnoea leading to tracheal intubation were frequently observed. ©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Ketamine; Pain; Respiratory distress syndrome; Sedation; Surfactant therapy

Mesh:

Substances:

Year:  2018        PMID: 29532502     DOI: 10.1111/apa.14317

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Premedication with ketamine or propofol for less invasive surfactant administration (LISA): observational study in the delivery room.

Authors:  Camille Brotelande; Christophe Milési; Clémentine Combes; Sabine Durand; Maliha Badr; Gilles Cambonie
Journal:  Eur J Pediatr       Date:  2021-05-06       Impact factor: 3.183

2.  Less invasive surfactant administration is associated with a higher need for nonpharmacological pain-relieving interventions compared to the intubation-surfactant extubation technique in preterm infants.

Authors:  Michaela Höck; Anna Posod; Maria Waltner-Romen; Ursula Kiechl-Kohlendorfer; Elke Griesmaier
Journal:  Paediatr Neonatal Pain       Date:  2020-11-27

Review 3.  New techniques, new challenges-The dilemma of pain management for less invasive surfactant administration?

Authors:  Ashanti Balakrishnan; Ranveer S Sanghera; Elaine M Boyle
Journal:  Paediatr Neonatal Pain       Date:  2020-07-09

4.  Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA).

Authors:  Marie Chevallier; Xavier Durrmeyer; Anne Ego; Thierry Debillon
Journal:  BMC Pediatr       Date:  2020-05-08       Impact factor: 2.125

5.  Quality assessment and response to less invasive surfactant administration (LISA) without sedation.

Authors:  Ellen de Kort; Suzanne Kusters; Hendrik Niemarkt; Carola van Pul; Irwin Reiss; Sinno Simons; Peter Andriessen
Journal:  Pediatr Res       Date:  2019-08-27       Impact factor: 3.756

Review 6.  Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?

Authors:  Venkatakrishna Kakkilaya; Kanekal Suresh Gautham
Journal:  Pediatr Res       Date:  2022-08-19       Impact factor: 3.953

7.  Teaching fiberoptic-assisted tracheoscopy in very low birth weight infants: A randomized controlled simulator study.

Authors:  Monika Wolf; Berenike Seiler; Valentina Vogelsang; Luke Sydney Hopf; Parisa Moll-Koshrawi; Eik Vettorazzi; Chinedu Ulrich Ebenebe; Dominique Singer; Philipp Deindl
Journal:  Front Pediatr       Date:  2022-09-08       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.